Skip to content

Investors

Investors

Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:

Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.

Events & Presentations
Annual Report and Proxy Statement
Date Title and Summary
Toggle Summary Arena Pharmaceuticals Announces Changes to Board of Directors
SAN DIEGO , Feb. 16, 2018 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced Scott H. Bice, Phillip M. Schneider , and Christine A. White , M.D. have indicated that they will be retiring from the Board of Directors at the time of Arena's next annual stockholders' meeting,
Toggle Summary Arena Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO , Feb. 6, 2018 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that that members of its senior management team will present at two upcoming investor conferences in New York City . LEERINK Partners 7 th Annual Global Healthcare Conference - Presenting on